These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 10948766

  • 1. Steroid sparing therapeutic approaches to polymyalgia rheumatica-giant cell arteritis. State of the art and perspectives.
    Ferraccioli GF, Di Poi E, Damato R.
    Clin Exp Rheumatol; 2000; 18(4 Suppl 20):S58-60. PubMed ID: 10948766
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.
    Gonzalez-Gay MA, Garcia-Porrua C, Miranda-Filloy JA, Martin J.
    Drugs Aging; 2006; 23(8):627-49. PubMed ID: 16964987
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.
    Askling J, Klareskog L, Hjalgrim H, Baecklund E, Björkholm M, Ekbom A.
    Ann Rheum Dis; 2005 Dec; 64(12):1765-8. PubMed ID: 15843445
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series.
    Adizie T, Christidis D, Dharmapaliah C, Borg F, Dasgupta B.
    Int J Clin Pract; 2012 Sep; 66(9):906-9. PubMed ID: 22897467
    [Abstract] [Full Text] [Related]

  • 7. Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis.
    Matteson EL, Buttgereit F, Dejaco C, Dasgupta B.
    Rheum Dis Clin North Am; 2016 Feb; 42(1):75-90, viii. PubMed ID: 26611552
    [Abstract] [Full Text] [Related]

  • 8. Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?
    van der Veen MJ, Dinant HJ, van Booma-Frankfort C, van Albada-Kuipers GA, Bijlsma JW.
    Ann Rheum Dis; 1996 Apr; 55(4):218-23. PubMed ID: 8733437
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Corticosteroid sparing agents for polymyalgia rheumatica and arteritis temporalis (Horton's disease)].
    Volken JJ, Karrer W.
    Praxis (Bern 1994); 2004 Jun 16; 93(25-26):1103-6. PubMed ID: 15317301
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
    Albrecht K, Huscher D, Buttgereit F, Aringer M, Hoese G, Ochs W, Thiele K, Zink A.
    Rheumatol Int; 2018 Apr 16; 38(4):569-577. PubMed ID: 29124397
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Polymyalgia rheumatica and giant cell arteritis: what's new?].
    Nissen MJ, Gabay C.
    Rev Med Suisse; 2010 Mar 17; 6(240):575-6, 578, 580. PubMed ID: 20408463
    [Abstract] [Full Text] [Related]

  • 15. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
    Buttgereit F, Dejaco C, Matteson EL, Dasgupta B.
    JAMA; 2016 Jun 14; 315(22):2442-58. PubMed ID: 27299619
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Polymyalgia rheumatica and giant-cell arteritis.
    Ostor AJ, Hazleman BL.
    N Engl J Med; 2002 Dec 19; 347(25):2083-5; author reply 2083-5. PubMed ID: 12490698
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Polymyalgia rheumatic (PMR): giant cell arteritis (GCA).
    Kelly MC.
    Ir Med J; 2008 Dec 19; 101(7):222-4. PubMed ID: 18807817
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.